Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer

Ma,Wenguang; Wang,Kun; Du,Jongqiang; Luan,Junqi; Lou,Ge

doi:10.3892/mmr.2014.3003

Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer

Authors:
- Wenguang Ma
- Kun Wang
- Jongqiang Du
- Junqi Luan
- Ge Lou
View Affiliations

Affiliations: Department of Gynecology, The Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Department of Anesthesiology, The Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Department of Anesthesiology, The First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China, Department of Gynecology, The First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China
Published online on: November 26, 2014 https://doi.org/10.3892/mmr.2014.3003
Pages: 2999-3008

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Analgesic treatment with anti‑inflammatory drugs may aid the prevention of postoperative pain and the attenuation of the postoperative immune inflammatory response. The current study presents a randomized, double‑blind controlled study, which was performed to investigate the levels of Th1, Th2, Th17 and Treg cytokines, including interleukin (IL)‑2, interferon (IFN)‑γ, IL‑4, IL‑10, IL‑17, IL‑23 and transforming growth factor (TGF)‑β in the peripheral blood of patients with cervical cancer following laparoscopy. The effects of perioperative multi‑dose parecoxib on postoperative immune function was evaluated. A total of 80 patients with cervical cancer (stage IB/IIA, ASA I‑III, aged 18‑65 years) that were scheduled for laparoscopy were randomly assigned into either the parecoxib (I; n=40) or control (II; n=40) groups. Group I received 40 mg parecoxib 30 min prior to surgery and then every 12 h subsequent to surgery for 60 h, and group II received normal saline at the corresponding time points. Intravenous tramadol (100 mg) was prescribed for pain relief as required. The mRNA and protein expression levels of cytokines in the peripheral blood were detected by quantitative polymerase chain reaction and ELISA. Pain visual analog scales (VAS) and incidence, analgesic relief, adverse events and the length of hospital stay were recorded. It was demonstrated that the mRNA and protein levels of IL‑2, IFN‑γ and IL‑17 in the two groups were reduced subsequent to surgery, while mRNA and protein expression levels of IL‑4, IL‑10 and TGF‑β were enhanced. Administration of multi‑dose parecoxib may diminish the increase in postoperative IL‑2, IFN‑γ and IL‑17 levels, and suppress the excessive production of IL‑4, IL‑10 and TGF‑β. This effect is accompanied by lower VAS scores, pain incidence, postoperative nausea/vomiting and infections. In conclusion, perioperative multi‑dose parecoxib was able to alleviate postoperative pain and ameliorate surgery‑induced immune suppression by balancing Th1, Th2, Th17 and Treg cytokines following laparoscopy in patients with cervical cancer. The current study provides support to the hypothesis that parecoxib may be a more effective therapeutic strategy than the currently available options, for postoperative pain and immune function management of patients with cancer.

View Figures

View References

1	Micheli DC, Fernandes PC Jr, Cruvinel JC, Nomelini ID, Murta EF and Tavares-Murta BM: Circulating cytokines and nitric oxide are involved in the inhibition of neutrophil migration in patients with uterine cervical neoplasia. Clin Med Insights Oncol. 6:233–242. 2012.PubMed/NCBI
2	Kosmaczewska A, Bocko D, Ciszak L, et al: Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression. Pathol Oncol Res. 18:479–489. 2012. View Article : Google Scholar :
3	Holub Z: Impact of laparoscopic surgery on immune function. Clin Exp Obstret Gynecol. 29:77–81. 2002.
4	Ling Y, Chen J, Tao M, Chu X and Zhang X: A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. J Thorac Dis. 4:58–62. 2012.PubMed/NCBI
5	Sah BK, Chen MM, Yan M and Zhu ZG: Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital. World J Gastroenterol. 16:98–103. 2010.
6	Salo M: Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand. 36:201–220. 1992. View Article : Google Scholar : PubMed/NCBI
7	Bürkle A, Caselli G, Franceschi C, et al: Pathophysiology of ageing, longevity and age related diseases. Immun Ageing. 4:42007. View Article : Google Scholar : PubMed/NCBI
8	Hou CY, Li XL, Jiang F, Gong RJ, Guo XY and Yao YQ: Comparative evaluation of surgical stress of laparoscopically assisted vaginal radical hysterectomy and lymphadenectomy and laparotomy for early-stage cervical cancer. Oncol Lett. 2:747–752. 2011.
9	Yang X, Qian F, He HY, et al: Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro. Braz J Med Biol Res. 45:25–32. 2012. View Article : Google Scholar : PubMed/NCBI
10	Hildesheim A, Schiffman MH, Tsukui T, et al: Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer Epidemiol Biomarkers Prev. 6:807–813. 1997.PubMed/NCBI
11	Park H, Li Z, Yang XO, et al: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
12	Stockinger B and Veldhoen M: Differentiation and function of Th17 T cells. Curr Opin Immunol. 19:281–286. 2007. View Article : Google Scholar : PubMed/NCBI
13	Chen Z, Ding J, Pang N, et al: The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagn Pathol. 8:612013. View Article : Google Scholar : PubMed/NCBI
14	Page GG: Surgery-induced immunosuppression and postoperative pain management. AACN Clin Issues. 16:302–309. 416–418. 2005. View Article : Google Scholar : PubMed/NCBI
15	Ling Y, Chen J, Tao M, Chu X and Zhang X: A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. J Thorac Dis. 4:58–62. 2012.PubMed/NCBI
16	Dembo G, Park SB and Kharasch ED: Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology. 102:409–415. 2005. View Article : Google Scholar : PubMed/NCBI
17	Mehta V, Johnston A, Cheung R, Bello A and Langford RM: Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system. Clin Pharmacol Ther. 83:430–435. 2008. View Article : Google Scholar
18	Koppert W, Wehrfritz A, Körber N, Sittl R, Albrecht S, Schüttler J and Schmelz M: The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain. 108:148–153. 2004. View Article : Google Scholar : PubMed/NCBI
19	Cheer SM and Goa KL: Parecoxib (parecoxib sodium). Drugs. 61:1133–1143. 2011. View Article : Google Scholar
20	Eberstål S, Badn W, Fritzell S, Esbjörnsson M, Darabi A, Visse E and Siesjö P: Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors. Cancer Immunol Immunother. 61:1191–1199. 2012. View Article : Google Scholar : PubMed/NCBI
21	Pandazi A, Kapota E, Matsota P, Paraskevopoulou P, Dervenis C and Kostopanagiotou G: Preincisional versus postincisional administration of parecoxib in colorectal surgery: effect on postoperative pain control and cytokine response. A randomized clinical trial. World J Surg. 34:2463–2469. 2010. View Article : Google Scholar : PubMed/NCBI
22	Peng M, Wang YL, Wang FF, Chen C and Wang CY: The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proinflammatory cytokine expression in the hippocampus in aged rats. J Surg Res. 178:e1–e8. 2012. View Article : Google Scholar : PubMed/NCBI
23	Li G, Yan X, Shang H, Wang G, Chen L and Han Y: A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer. Gynecol Oncol. 105:176–180. 2007. View Article : Google Scholar : PubMed/NCBI
24	Clapcich AJ, Emerson RG, Roye DP Jr, Xie H, Gallo EJ, Dowling KC, Ramnath B and Heyer EJ: The effects of propofol, small-dose isoflurane, and nitrous oxide on cortical somatosensory evoked potential and bispectral index monitoring in adolescents undergoing spinal fusion. Anesth Analg. 99:1334–1340. 2004. View Article : Google Scholar : PubMed/NCBI
25	Jabbour-Khoury SI, Dabbous AS, Gerges FJ, Azar MS, Ayoub CM and Khoury GS: Intraperitoneal and intravenous routes for pain relief in laparoscopic cholecystectomy. JSLS. 9:316–321. 2005.PubMed/NCBI
26	Chen LC, Elliott RA and Ashcroft DM: Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control. J Clin Pharm Ther. 29:215–229. 2004. View Article : Google Scholar : PubMed/NCBI
27	Straube S, Derry S, McQuay HJ and Moore RA: Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies. Acta Anaesthesiol Scand. 49:601–613. 2005. View Article : Google Scholar : PubMed/NCBI
28	Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D and Hubbard RC: The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg. 93:721–727. 2001. View Article : Google Scholar : PubMed/NCBI
29	Zhang H, Shu H, Yang L, et al: Multiple-, but not single-, dose of parecoxib reduces shoulder pain after gynecologic laparoscopy. Int J Med Sci. 9:757–765. 2012. View Article : Google Scholar : PubMed/NCBI
30	Barton SF, Langeland FF, Snabes MC, LeComte D, Kuss ME, Dhadda SS and Hubbard RC: Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology. 97:306–314. 2002. View Article : Google Scholar : PubMed/NCBI
31	Warrino DE, Olson WC, Knapp WT, et al: Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes. Clin Cancer Res. 10:3301–3308. 2004. View Article : Google Scholar : PubMed/NCBI
32	Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM and Huang SC: Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol. 167:2972–2978. 2001. View Article : Google Scholar : PubMed/NCBI
33	Rao PE, Petrone AL and Ponath PD: Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-beta. J Immunol. 174:1446–1455. 2005. View Article : Google Scholar : PubMed/NCBI
34	Navarro-Zorraquino M, García-Alvarez F, Martínez-Fernández AR, Pastor C, Larrad L, Salinas JC and Lozano R: Pharmacological immunomodulation of surgical trauma. J Invest Surg. 20:283–289. 2007. View Article : Google Scholar : PubMed/NCBI
35	Visser J, Nijman HW, Hoogenboom BN, et al: Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin Exp Immunol. 150:199–209. 2007. View Article : Google Scholar : PubMed/NCBI
36	Cheng YC, Cheng XB, Li XJ, Wang FZ and Li ZK: Combined general and regional anesthesia and effects on immune function in patients with benign ovarian tumors treated by laparoscopic therapy. Int J Clin Exp Med. 6:716–719. 2013.PubMed/NCBI
37	Hunter JD: Effects of anaesthesia on the human immune system. Hosp Med. 60:658–663. 1999. View Article : Google Scholar
38	Engers R, Mueller M, Walter A, Collard JG, Willers R and Gabbert HE: Prognostic relevance of Tiam1 protein expression in prostate carcinomas. Br J Cancer. 95:1081–1086. 2006. View Article : Google Scholar : PubMed/NCBI
39	Gehling M, Arndt C, Eberhart LH, Koch T, Krüger T and Wulf H: Postoperative analgesia with parecoxib, acetaminophen, and the combination of both: a randomized, double-blind, placebo-controlled trial in patients undergoing thyroid surgery. Br J Anaesth. 104:761–767. 2010. View Article : Google Scholar : PubMed/NCBI
40	Ang SF, Sio SW, Moochhala SM, MacAry PA and Bhatia M: Hydrogen sulfide upregulates cyclooxygenase-2 and prostaglandin E metabolite in sepsis-evoked acute lung injury via transient receptor potential vanilloid type 1 channel activation. J Immunol. 187:4778–4787. 2011. View Article : Google Scholar : PubMed/NCBI
41	Bao Y, Fang J, Peng L, Yi Y, Liu K, Li W and Luo H: Comparison of preincisional and postincisional parecoxib administration on postoperative pain control and cytokine response after total hip replacement. J Int Med Res. 40:1804–1811. 2012. View Article : Google Scholar : PubMed/NCBI
42	Sharma S, Zhu L, Yang SC, et al: Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses. J Immunol. 175:813–819. 2005. View Article : Google Scholar : PubMed/NCBI
43	Kundu N, Walser TC, Ma X and Fulton AM: Cyclooxygenase inhibitors modulate NK activities that control metastatic disease. Cancer Immunol Immunother. 54:981–987. 2005. View Article : Google Scholar : PubMed/NCBI
44	Jiang S, Liu X, Luo L, et al: Serum levels of Th17-related cytokines in Behcet disease patients after cataract surgery. Mol Vis. 17:1425–1430. 2011.PubMed/NCBI
45	Sacerdote P, Bianchi M, Gaspani L, et al: The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 90:1411–1414. 2000. View Article : Google Scholar : PubMed/NCBI